Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,965 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
Hosogaya N, Miyazaki T, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Kurokawa T, Kawasaki Y, Hanawa M, Fujii Y, Hanaoka H, Iwami S, Watashi K, Yamagoe S, Miyazaki Y, Wakita T, Izumikawa K, Yanagihara K, Mukae H, Kohno S; Nelfinavir Study Group. Hosogaya N, et al. Among authors: kawasaki y. Trials. 2021 Apr 28;22(1):309. doi: 10.1186/s13063-021-05282-w. Trials. 2021. PMID: 33910617 Free PMC article.
Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial).
Mitsuhashi A, Kawasaki Y, Hori M, Fujiwara T, Hanaoka H, Shozu M. Mitsuhashi A, et al. Among authors: kawasaki y. BMJ Open. 2020 Feb 28;10(2):e035416. doi: 10.1136/bmjopen-2019-035416. BMJ Open. 2020. PMID: 32114477 Free PMC article. Clinical Trial.
Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer.
Toyoda T, Kamata T, Tanaka K, Ihara F, Takami M, Suzuki H, Nakajima T, Ikeuchi T, Kawasaki Y, Hanaoka H, Nakayama T, Yoshino I, Motohashi S. Toyoda T, et al. Among authors: kawasaki y. J Immunother Cancer. 2020 Mar;8(1):e000316. doi: 10.1136/jitc-2019-000316. J Immunother Cancer. 2020. PMID: 32188702 Free PMC article. Clinical Trial.
HAMAMATSU-ICG study: Protocol for a phase III, multicentre, single-arm study to assess the usefulness of indocyanine green fluorescent lymphography in assessing secondary lymphoedema.
Akita S, Unno N, Maegawa J, Kimata Y, Fukamizu H, Yabuki Y, Shinaoka A, Sano M, Kawasaki Y, Fujiwara T, Hanaoka H, Mitsukawa N. Akita S, et al. Among authors: kawasaki y. Contemp Clin Trials Commun. 2020 Jun 16;19:100595. doi: 10.1016/j.conctc.2020.100595. eCollection 2020 Sep. Contemp Clin Trials Commun. 2020. PMID: 32617434 Free PMC article.
Cognitive-behavioral family therapy as psychoeducation for adolescents with high-functioning autism spectrum disorders: Aware and Care for my Autistic Traits (ACAT) program study protocol for a pragmatic multisite randomized controlled trial.
Oshima F, William M, Takahashi N, Tsuchiyagaito A, Kuwabara H, Shiina A, Seto M, Hongo M, Iwama Y, Hirano Y, Sutoh C, Taguchi K, Yoshida T, Kawasaki Y, Ozawa Y, Masuya J, Sato N, Nakamura S, Kuno M, Takahashi J, Ohtani T, Matsuzawa D, Inada N, Kuroda M, Ando M, Hori A, Nakagawa A, Shimizu E. Oshima F, et al. Among authors: kawasaki y. Trials. 2020 Sep 29;21(1):814. doi: 10.1186/s13063-020-04750-z. Trials. 2020. PMID: 32993775 Free PMC article.
A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
Namiki T, Takayama S, Arita R, Ishii T, Kainuma M, Makino T, Mimura M, Yoshino T, Nogami T, Arai M, Sato J, Tanaka K, Nakae H, Igari H, Ozawa Y, Shiko Y, Kawasaki Y, Nezu M, Ito T. Namiki T, et al. Among authors: kawasaki y. Trials. 2021 Jan 6;22(1):23. doi: 10.1186/s13063-020-04939-2. Trials. 2021. PMID: 33407828 Free PMC article.
Randomized trial of granulocyte colony-stimulating factor for spinal cord injury.
Koda M, Hanaoka H, Fujii Y, Hanawa M, Kawasaki Y, Ozawa Y, Fujiwara T, Furuya T, Ijima Y, Saito J, Kitamura M, Miyamoto T, Ohtori S, Matsumoto Y, Abe T, Takahashi H, Watanabe K, Hirano T, Ohashi M, Shoji H, Mizouchi T, Kawahara N, Kawaguchi M, Orita Y, Sasamoto T, Yoshioka M, Fujii M, Yonezawa K, Soma D, Taneichi H, Takeuchi D, Inami S, Moridaira H, Ueda H, Asano F, Shibao Y, Aita I, Takeuchi Y, Mimura M, Shimbo J, Someya Y, Ikenoue S, Sameda H, Takase K, Ikeda Y, Nakajima F, Hashimoto M, Hasue F, Fujiyoshi T, Kamiya K, Watanabe M, Katoh H, Matsuyama Y, Hasegawa T, Yoshida G, Arima H, Yamato Y, Oe S, Togawa D, Kobayashi S, Akeda K, Kawamoto E, Imai H, Sakakibara T, Sudo A, Ito Y, Kikuchi T, Takigawa T, Morita T, Tanaka N, Nakanishi K, Kamei N, Kotaka S, Baba H, Okudaira T, Konishi H, Yamaguchi T, Ito K, Katayama Y, Matsumoto T, Matsumoto T, Kanno H, Aizawa T, Hashimoto K, Eto T, Sugaya T, Matsuda M, Fushimi K, Nozawa S, Iwai C, Taguchi T, Kanchiku T, Suzuki H, Nishida N, Funaba M, Sakai T, Imajo Y, Yamazaki M. Koda M, et al. Among authors: kawasaki y. Brain. 2021 Apr 12;144(3):789-799. doi: 10.1093/brain/awaa466. Brain. 2021. PMID: 33764445 Free PMC article. Clinical Trial.
A phase III, multicenter, single-arm study to assess the utility of indocyanine green fluorescent lymphography in the treatment of secondary lymphedema.
Akita S, Unno N, Maegawa J, Kimata Y, Fukamizu H, Yabuki Y, Kitayama S, Shinaoka A, Yamada K, Sano M, Ota Y, Ohnishi F, Sakuma H, Nuri T, Ozawa Y, Shiko Y, Kawasaki Y, Hanawa M, Fujii Y, Imanishi E, Fujiwara T, Hanaoka H, Mitsukawa N. Akita S, et al. Among authors: kawasaki y. J Vasc Surg Venous Lymphat Disord. 2022 May;10(3):728-737.e3. doi: 10.1016/j.jvsv.2021.09.006. Epub 2021 Sep 27. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 34592477
1,965 results